Multinational pharmaceutical companies (MNCs) operating in China’s vaccine market face growing challenges as regulatory scrutiny, intensifying domestic competition, and shifting consumer ...

The Financial Times estimates that China makes around 13% of Nvidia's yearly income, or around $17.1 billion.Nvidia is looking for talks with high-level Chinese authorities and is changing the H20 ...